Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Malcolm Spicer

US Consumer Health Managing Editor

Washington, DC
Malcolm has expertly covered the OTC drug and nutritional supplement industries and markets since 2006. He provides authoritative and highly analytical insight into how and why the US Food and Drug Administration regulates OTC drugs, including homeopathics, and nutritional supplement manufacturing and marketing and also how companies competing in these industries can most efficiently and effectively comply with FDA regulations, the cornerstone for their success.

Latest From Malcolm Spicer

US Health And Wellness People News: Nutrabolt, Ghost, MyFitnessPal, Med-Bev, Ahara, More

Nutrabolt Corp. appoints Jason Lin CGO; Ghost partners with Phillies; MyFitnessPal adds CPO; Med-Bev Natural Diabetic-Friendly Drink gets NFL player’s assist; another NFL player on Recover 180 team; Whoop expands management; and personalized nutrition expert heads Ahara’s advisors.

Executive Changes Dietary Supplements

Former FTC Member Harbour Appointed To Radicle Science's Advisory Board

Pamela Jones Harbour joins provider of "proof-as-a-service'' testing technology for supplements and natural products as industry navigates evolving expectations, including FTC’s 2022 Health Products Compliance Guidance update. 

Executive Changes Consumer

US FDA Clearance For Masimo’s Stork Wakes Up OTC Baby Monitoring Technology Competition

Masimo receives US regulatory clearance for Stork OTC baby monitoring system six months after Owlet received first clearance for its Dream Sock following a regulatory stumble which halted sales of a previous device, Smart Sock, in 2021.

OTC Devices Approvals

US FDA Clearance For Masimo’s Stork Delivers OTC Baby Monitoring Tech Competition

Masimo receives US regulatory clearance for Stork OTC baby monitoring system six months after Owlet received first clearance for its Dream Sock following a regulatory stumble which halted sales of a previous device, Smart Sock, in 2021.

Approvals OTC Devices

US Competition To Connect Obesity Drug Patients With Supplements Attracts Retail Heavyweights

Vitamin Shoppe announces Whole Health Rx telehealth services offering supplements for GLP-1 patients and access to doctors for prescribing the drugs a week after GNC said it was “first major retailer to establish an entire section dedicated to assisting GLP-1 users.”

Dietary Supplements Telehealth

Opill Launch Delivers For Perrigo While Growing Pains Slow Overall First-Quarter Results

Perrigo spares little about Opill’s launch, advertising and outlook in Q1 earnings briefing, but management also makes clear it’s a large firm and some other segments of its global consumer health products business are holding back overall results.

Sales & Earnings Women's Health
See All
UsernamePublicRestriction

Register